MS News: April 2015
- Miconazole and clobetasol may be effective as multiple sclerosis therapies
- Drug Derived From Sea Anemone Shows Promise Against Psoriasis, MS
- Novel Drug From Nature Shows Early Promise
- ‘Brainbow’ illuminates cellular connections
- MS Association of America releases 2015 multiple sclerosis research update
- B Vitamin Promising in Progressive Multiple Sclerosis
- Phenytoin protects against optical damage in multiple sclerosis
- Could Eczema Cream Be Used for Treating Multiple Sclerosis?
- URMC Start-up Takes Aim at Memory and Cognitive Problems
- Controversial stem cell treatment for multiple sclerosis
- Key Cytokine Discovery May Shape Future MS Treatment
- The UpBeat: One of the ‘super heroes’ encouraged by promising MS research
- Drugs that activate brain stem cells may reverse multiple sclerosis
- Novel Mechanism May Prevent Onset of MS in Immune Cells
- French firm announces multiple sclerosis drug breakthrough
- A Missing Subset in ME/CFS and Fibromyalgia Revealed? Take the Disease Course Survey
- Stem Cell Transplant Reduces Multiple Sclerosis Disease Activity
- Seizure Medication Reduced Optic Neuritis In Multiple Sclerosis
- Tisch MS Research Center Of New York Reports Early Improvement In Stem Cell Trial
- Public Release: 22-Apr-2015 Researchers discover new drugs to combat the root cause of multiple …
- Progressive MS Pipeline Slowly Filling With New, Experimental Therapies
- Important Multiple Sclerosis Research Grants Announced
- Promising New Therapy for Multiple Sclerosis Based on Placenta Cells
Clinical trials
- GliaCure Initiates Phase 1b Dosing in Alzheimer’s Patients
- Opexa Developing Tcelna as a True Personalized MS Therapy For SPMS, RRMS
- Clinical trial for guanabenz as treatment for Multiple Sclerosis begins enrollment
- Myelin Repair Foundation and NIH begin clinical studies of guanabenz to treat multiple sclerosis
- New Tx for Relapsing MS Moves Closer to Approval as FDA Accepts BLA for Review
- Baseline Characteristics of 228 Subjects Enrolled in MediciNova’s Phase 2b Trial of M.
- Teva and Active Biotech Announce First Patient Enrolled in Phase II Study Evaluating Laquinimod …
- New candidate drug ‘dials down’ protein synthesis to treat demyelinating diseases
- New Drug Treatment Can Save Multiple Sclerosis Sufferers From Blindness
- MedDay’s Phase III trial of multiple sclerosis therapy meets primary endpoint
Medical treatment news
- Gamma knife an alternative
- Senator Alexander Says FDA And NIH Must Be Ready For Medical Breakthroughs That Are Coming
- FDA Accepts Bayer’s BETACONNECT License Application for Relapsing-Remitting Multiple Sclerosis
- Interferon beta and glatiramer acetate are cost-effective treatments for multiple sclerosis
- MRI Data Indicate Slowing of Brain Atrophy with Lemtrada
- Increasing Tysabri Dosing Interval May Cut PML Risk
- New Multiple Sclerosis Model Visualizes Disease Course
- Progressive Multiple Sclerosis Responds to Biotin
- Sandoz receives US FDA approval for generic Copaxone to treat relapsing forms of multiple sclerosis
Holistic treatment news
- Exercise program shows promising results for multiple sclerosis patients
- Hawaii committee passes medical marijuana dispensaries bill
- Lopez bill legalizes medical marijuana for children
- Massage helps ease the body as well as the mind
- New Cannabis and Cannabinoid Research journal to be launched in fall 2015
- Extending natalizumab up to 8 weeks shown safe and effective in patients with MS
Business news
- Showcase, May 2015
- Recent research into the multiple sclerosis drugs market – global size, share, trends analysis and …
- Teva Pharmaceutical Industries Ltd (TEVA) Q1 Earnings Rise 11%; Sales Exceed Forecast
- Research and Markets: Global Primary Progressive Multiple Sclerosis (PPMS) Pipeline Report 2015
- CorTechs Labs, Novartis partner to advance clinical care, assessment of multiple sclerosis worldwide
- International Survey from Biogen Identifies Opportunities for Improving MS Treatment Satisfaction
- 3 Biotech Stocks That Could Be Developing Billion Dollar Drugs
General news
- Richard Pryor Sculpture To Stand In Hometown Of Peoria, Illinois
- Ann Romney, who has multiple sclerosis, launches social media campaign on neurologic illnesses
- Montel Williams Talks Teaming Up with Jack Osbourne and Ann Romney to Fight MS
- Mobile App Available for Leading Multiple Sclerosis Conference for Healthcare Professionals
- App That Spots Depression Ready For Primetime
- Aspartame dropped from US Diet Pepsi – why not in Britain too?
- My battle with multiple sclerosis by ex-pro golfer who played with Jack Nicklaus & Ian Woosnam
- Former Mass. First Lady Ann Romney Launches Social Media Campaign on Neurological Diseases
- VIDEO: Why Ann Romney, Jack Osbourne and Montel Williams Are Joining Forces
- MS Awareness Week: 7 Things People With Multiple Sclerosis Want You To Know
- Tommy Hilfiger has been honored for his work with multiple sclerosis
- Tommy Hilfiger Opens Up About His Commitment to Find a Cure for MS
©Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me, 2011-2015. Unauthorised use and/or duplication of this material without express and written permission from this blog’s author and/or owner are strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Willeke Van Eeckhoutte and Ireland, Multiple Sclerosis & Me with appropriate and specific direction to the original content.

No Comments
supportouramericanwarheroes.wordpress.com
Reblogged this on LIFE MATTERS FOR DISABLED AMERICANS.